HyperRAB® (rabies immune globulin [human])
The only human rabies immunoglobulin (HRIG) with a higher-potency formulation, offering potentially fewer injections in administration of each dose.
Use the only HRIG that offers
HyperRAB is indicated for postexposure prophylaxis, along with rabies vaccine, for all persons suspected of exposure to rabies.
Persons who have been previously immunized with rabies vaccine and have a confirmed adequate rabies antibody titer should receive only vaccine.
For unvaccinated persons, the combination of HyperRAB and vaccine is recommended for both bite and nonbite exposures regardless of the time interval between exposure and initiation of postexposure prophylaxis.
Trust more than 40 years of leadership. HyperRAB1,2:
- Mercury (thimerosal), latex, and preservative free
- Food and Drug Administration (FDA) labeling for capacity to remove pathogenic prions
- Low procoagulant activity
- Low levels of IgG aggregates
- Tamper-evident packaging